Advisory Council on Blood Stem Cell Transplantation; Notice of Meeting, 22791-22792 [2012-9135]

Download as PDF Federal Register / Vol. 77, No. 74 / Tuesday, April 17, 2012 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children; Notice of Meeting wreier-aviles on DSK5TPTVN1PROD with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Public Law 92–463, codified at 5 U.S.C. App. 2), notice is hereby given of the following meeting: Name: Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children. Dates and Times: May 17, 2012, 8:30 a.m. to 5 p.m. May 18, 2012, 8:30 a.m. to 2:30 p.m. Place: Hilton Alexandria Old Town Hotel, 1767 King Street, Alexandria, VA 22314. Status: The meeting will be open to the public, but seating will be limited by the space available. Participants are asked to register for the meeting by going to the registration Web site at https:// altarum.cvent.com/sachdncmay2012. The registration deadline is Tuesday, May 15, 2012. Individuals who need special assistance, such as sign language interpretation or other reasonable accommodations, should indicate their needs on the registration Web site. The deadline for special accommodation requests is Friday, May 11, 2012. If there are technical problems gaining access to the registration Web site, please contact Maureen Ball, Meetings Coordinator, at conferences@altarum.org. Purpose: The Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children (the Advisory Committee), as authorized by Public Law 106–310, which added section 1111 of the Public Health Service Act, codified at 42 U.S.C. 300b–10, was established by Congress to advise the Secretary of the Department of Health and Human Services in connection with the development of newborn screening activities, technologies, policies, guidelines and programs for effectively reducing morbidity and mortality in newborns and children having (or at risk for) heritable disorders. The Advisory Committee’s recommendations regarding additional conditions/inherited disorders for screening that are adopted by the Secretary are included in the Recommended Uniform Screening Panel (RUSP), which forms a part of the comprehensive guidelines supported by the Health Resources and Services Administration. Pursuant to section 2713 of the Public Health Service Act, codified at 42 U.S.C. 300gg–13, non-grandfathered health plans are required to cover screenings provided for in the comprehensive guidelines without charging a co-payment, co-insurance, or deductible for plan years (in the individual market these are known as policy years) beginning on or after the date that is one year from the Secretary’s adoption of the screening. The Advisory Committee also provides advice and recommendations concerning grants and projects authorized VerDate Mar<15>2010 14:27 Apr 16, 2012 Jkt 226001 under section 1109 of the Public Health Service Act (42 U.S.C. 300b–8). Agenda: The meeting will include: (1) Updates on the policies and procedures of the Advisory Committee; (2) presentation on the newborn screening case definitions project; (3) discussion and prioritization of plans and projects for the standing subcommittees; (4) updates from the Nomination and Prioritization Workgroup and the Condition Review Workgroup; (5) reports on medical foods, medical home and carrier screening; and (6) presentations on the continued work and reports of the Advisory Committee’s subcommittees: Laboratory Standards and Procedures; Follow-up and Treatment; and Education and Training. Tentatively, the Advisory Committee is expected to review and/or vote on the following items (none of which involve proposed addition of conditions to the RUSP): (1) Priorities for the subcommittees; (2) whether to refer the MPS I condition nomination package and the Pompe condition nomination package to the Condition Review Workgroup for further evaluation; (3) Condition Review Process Report; (3) Medical Home Manuscript; (4) Medical Foods Manuscript; and (5) NBS Awareness Campaign Strategy Report. Proposed agenda items are subject to change as priorities dictate. The agenda, Committee Roster and Charter, presentations, and meeting materials can be found at the homepage of the Advisory Committee’s Web site at https://www.hrsa.gov/ heritabledisorderscommittee/. Public Comments: Members of the public can submit written comments and/or present oral comments during the public comment periods of the meeting. All comments, whether oral or written, are part of the official Committee record and will be available for public inspection and copying. All written and oral comments should contain the name, address, telephone number, and professional or business affiliation of the author. Those individuals who want to make oral comments must note this as part of the online registration process by 5 p.m. EDT, Tuesday, May 15, 2012 at https://altarum.cvent.com/sachdncmay2012. Pre-registration is required in order to present oral comments. Presentations will be limited to five to ten minutes depending on the number of presenters. Oral comments will be heard on May 17, 2012. Individuals who are associated with groups having similar interests are requested to combine their comments and present them through a single representative. To ensure that all preregistered individuals who wish to make oral comments have the opportunity to share their comments, no audiovisual presentations are permitted. Written comments should be sent or emailed by Tuesday, May 15, 2012 to Maureen Ball (conferences@altarum.org), Meetings Coordinator, Conference and Meetings Management, Altarum Institute, 1200 18th Street NW., Suite 700, Washington, DC 20036. Comments may also be faxed (202–785–3083). If you have additional questions regarding the submission of comments, please contact Ms. Ball at 202–828–5100. Contact Person: Anyone interested in obtaining other relevant information should PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 22791 contact or write to Debi Sarkar, Maternal and Child Health Bureau, Health Resources and Services Administration, Room 18A–19, Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857; telephone: 301– 443–1080; email: dsarkar@hrsa.gov. More information on the Advisory Committee is available at https://mchb.hrsa.gov/ heritabledisorderscommittee. Dated: April 10, 2012. Reva Harris, Acting Director, Division of Policy and Information Coordination. [FR Doc. 2012–9136 Filed 4–16–12; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Advisory Council on Blood Stem Cell Transplantation; Notice of Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), notice is hereby given of the following meeting: Name: Advisory Council on Blood Stem Cell Transplantation. Date and Times: May 9, 2012, 8 a.m. to 4:30 p.m. Place: Georgetown University Hotel and Conference Center, 3800 Reservoir Road NW., Washington, DC 20057. Status: The meeting will be open to the public. Purpose: Pursuant to Public Law 109–129, 42 U.S.C. 274k (section 379 of the Public Health Service Act, as amended), the Advisory Council on Blood Stem Cell Transplantation (ACBSCT) advises the Secretary of HHS and the Administrator, HRSA, on matters related to the activities of the C.W. Bill Young Cell Transplantation Program (Program) and the National Cord Blood Inventory (NCBI) Program. Agenda: The Council will hear reports from five ACBSCT Work Groups: (1) Realizing the Potential of Cord Blood, (2) Scientific Factors Necessary to Define a Cord Blood Unit as High Quality, (3) Cord Blood Thawing and Washing, (4) Access to Transplantation, and (5) Advancing Hematopoietic Stem Cell Transplantation for Hemoglobinopathies. The Council also will hear presentations and discussions on topics including: Collection of information on Cellular Therapies; Adverse Event Reporting; and Unmet Need. Agenda items are subject to change as priorities dictate. After the presentations and Council discussions, members of the public will have an opportunity to provide comments. Because of the Council’s full agenda and the timeframe in which to cover the agenda topics, public comments will be limited. All public comments will be included in the record of the ACBSCT meeting. Meeting E:\FR\FM\17APN1.SGM 17APN1 22792 Federal Register / Vol. 77, No. 74 / Tuesday, April 17, 2012 / Notices summary notes will be made available on HRSA’s Program Web site at https:// bloodcell.transplant.hrsa.gov/ABOUT/ Advisory_Council/. Those planning to attend are requested to register in advance and those wishing to make oral comments should so indicate. The draft meeting agenda and a registration form will be available on HRSA’s Program Web site at https://bloodcell.transplant.hrsa.gov/ ABOUT/Advisory_Council/. Registration also can be completed electronically at https:// www.acbsct.com or by sending an email to Tristan Alexander Hicks at TAlexander@luxcg.com. Individuals without access to the Internet who wish to register may call Tristan Alexander Hicks at (301) 585–1261 or submit a facsimile to Lux Consulting Group, Inc., the logistical support contractor for the meeting, at fax number (301) 585–7741, Attn: Tristan Alexander Hicks. FOR FURTHER INFORMATION CONTACT: Patricia Stroup, Executive Secretary, Healthcare Systems Bureau, Health Resources and Services Administration, 5600 Fishers Lane, Room 12C–06, Rockville, Maryland 20857; telephone (301) 443–1127. Dated: April 10, 2012. Reva Harris, Acting Director, Division of Policy and Information Coordination. [FR Doc. 2012–9135 Filed 4–16–12; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Non-Competitive Program Expansion Supplement To Revise, Update, and Disseminate Educational Curricula Regarding Alzheimer’s Disease and Related Dementias Health Resources and Services Administration, HHS. ACTION: Notice of a Non-Competitive Program Expansion Supplement To Revise, Update, and Disseminate Educational Curricula Regarding Alzheimer’s Disease and Related Dementias. AGENCY: The Health Resources and Services Administration (HRSA) will be issuing a non-competitive program expansion supplement to 45 Geriatric Education Centers (GEC) Program grantees to revise, update, and disseminate educational curricula regarding Alzheimer’s Disease and related dementias (AD). Approximately $2,000,000 will be available in Fiscal Year (FY) 2012 and $4,000,000 in FY 2013 from the Prevention and Public Health Fund, created by the Affordable Care Act. The GEC grantees have the capacity, capability, expertise, experience, and infrastructure to expeditiously, effectively, and efficiently implement the AD initiative within their existing educational programming. The programmatic supplements will allow the Bureau of Health Professions to consolidate resources and provide enhanced technical assistance, grant funds, grant monitoring and oversight to the AD initiative within currently existing grants. SUMMARY: SUPPLEMENTARY INFORMATION: Grantees of record and intended award amounts are: 2012 Projected awards 2012 Supplement amount wreier-aviles on DSK5TPTVN1PROD with NOTICES Grantee name Grant No. State University of Alabama at Birmingham ................................ Arizona Board of Regents ................................................... University of Arkansas ........................................................ Board of Trustees of the Leland Stanford Junior University. The Regents of the University of California, Los Angeles The Regents of the University of California, San Francisco. NOVA Southeastern University ........................................... University of Miami .............................................................. Emory University ................................................................. University of Hawaii ............................................................ University of Iowa ................................................................ University of Kansas Medical Center Research Institute ... University of Kentucky Research Foundation ..................... University of New England .................................................. Johns Hopkins University .................................................... Regents of the University of Minnesota .............................. Saint Louis University ......................................................... The University of Montana .................................................. Board of Regents, NSHE, on behalf of University of Nevada—Reno. Trustees of Dartmouth College ........................................... UMDNJ—School of Osteopathic Medicine ......................... Mount Sinai School of Medicine ......................................... University of Rochester ....................................................... Duke University ................................................................... University of North Carolina at Chapel Hill ......................... University of Oklahoma Health Sciences Center ............... Oregon Health and Science University ............................... Thomas Jefferson University .............................................. University of Pennsylvania .................................................. University of Pittsburgh ....................................................... University of Rhode Island .................................................. University of South Carolina ............................................... Meharry Medical College .................................................... Baylor College of Medicine ................................................. Texas Tech University Health Sciences Center ................. UB4HP19045 UB4HP19047 UB4HP19048 UB4HP19049 Alabama ............................... Arizona ................................. Arkansas .............................. California .............................. $216,000.00 399,771.00 421,310.00 399,772.00 $42,222 42,222 42,222 42,222 UB4HP19202 UB4HP19046 California .............................. California .............................. 426,192.00 424,203.00 42,222 42,222 UB4HP19211 UB4HP19066 UB4HP19215 UB4HP19065 UB4HP19054 UB4HP19192 UB4HP19051 UB4HP19207 UB4HP19193 UB4HP19196 UB4HP19060 UB4HP19056 UB4HP19205 Florida .................................. Florida .................................. Georgia ................................ Hawaii .................................. Iowa ...................................... Kansas ................................. Kentucky .............................. Maine ................................... Maryland .............................. Minnesota ............................. Missouri ................................ Montana ............................... Nevada ................................. 431,907.00 427,185.00 419,472.00 427,920.00 426,650.00 429,472.00 409,280.00 216,000.00 426,800.00 424,811.00 427,879.00 429,725.00 418,751.00 42,222 42,222 42,222 42,222 42,222 42,222 42,222 42,222 42,222 42,222 42,222 42,222 42,222 UB4HP19206 UB4HP19059 UB4HP19194 UB4HP19204 UB4HP19203 UB4HP19053 UB4HP19197 UB4HP19057 UB4HP19061 UB4HP19214 UB4HP19199 UB4HP19208 UB4HP19212 UB4HP19055 UB4HP19052 UB4HP19201 New Hampshire .................... New Jersey .......................... New York ............................. New York ............................. North Carolina ...................... North Carolina ...................... Oklahoma ............................. Oregon ................................. Pennsylvania ........................ Pennsylvania ........................ Pennsylvania ........................ Rhode Island ........................ South Carolina ..................... Tennessee ........................... Texas ................................... Texas ................................... 425,443.00 423,459.00 421,698.00 415,498.00 215,713.00 420,000.00 416,609.00 418,002.00 417,200.00 427,795.00 416,712.00 424,589.00 422,640.00 418,222.00 414,000.00 215,216.00 42,222 42,222 42,222 42,222 42,222 42,222 42,222 42,222 42,222 42,222 42,222 42,222 42,222 42,222 42,222 42,222 VerDate Mar<15>2010 14:27 Apr 16, 2012 Jkt 226001 PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 E:\FR\FM\17APN1.SGM 17APN1

Agencies

[Federal Register Volume 77, Number 74 (Tuesday, April 17, 2012)]
[Notices]
[Pages 22791-22792]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-9135]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Council on Blood Stem Cell Transplantation; Notice of 
Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), notice is hereby given of the following 
meeting:

    Name: Advisory Council on Blood Stem Cell Transplantation.
    Date and Times: May 9, 2012, 8 a.m. to 4:30 p.m.
    Place: Georgetown University Hotel and Conference Center, 3800 
Reservoir Road NW., Washington, DC 20057.
    Status: The meeting will be open to the public.
    Purpose: Pursuant to Public Law 109-129, 42 U.S.C. 274k (section 
379 of the Public Health Service Act, as amended), the Advisory 
Council on Blood Stem Cell Transplantation (ACBSCT) advises the 
Secretary of HHS and the Administrator, HRSA, on matters related to 
the activities of the C.W. Bill Young Cell Transplantation Program 
(Program) and the National Cord Blood Inventory (NCBI) Program.
    Agenda: The Council will hear reports from five ACBSCT Work 
Groups: (1) Realizing the Potential of Cord Blood, (2) Scientific 
Factors Necessary to Define a Cord Blood Unit as High Quality, (3) 
Cord Blood Thawing and Washing, (4) Access to Transplantation, and 
(5) Advancing Hematopoietic Stem Cell Transplantation for 
Hemoglobinopathies. The Council also will hear presentations and 
discussions on topics including: Collection of information on 
Cellular Therapies; Adverse Event Reporting; and Unmet Need. Agenda 
items are subject to change as priorities dictate.

    After the presentations and Council discussions, members of the 
public will have an opportunity to provide comments. Because of the 
Council's full agenda and the timeframe in which to cover the agenda 
topics, public comments will be limited. All public comments will be 
included in the record of the ACBSCT meeting. Meeting

[[Page 22792]]

summary notes will be made available on HRSA's Program Web site at 
https://bloodcell.transplant.hrsa.gov/ABOUT/Advisory_Council/.
    Those planning to attend are requested to register in advance and 
those wishing to make oral comments should so indicate. The draft 
meeting agenda and a registration form will be available on HRSA's 
Program Web site at https://bloodcell.transplant.hrsa.gov/ABOUT/Advisory_Council/.
    Registration also can be completed electronically at https://www.acbsct.com or by sending an email to Tristan Alexander Hicks at 
TAlexander@luxcg.com. Individuals without access to the Internet who 
wish to register may call Tristan Alexander Hicks at (301) 585-1261 or 
submit a facsimile to Lux Consulting Group, Inc., the logistical 
support contractor for the meeting, at fax number (301) 585-7741, Attn: 
Tristan Alexander Hicks.

FOR FURTHER INFORMATION CONTACT: Patricia Stroup, Executive Secretary, 
Healthcare Systems Bureau, Health Resources and Services 
Administration, 5600 Fishers Lane, Room 12C-06, Rockville, Maryland 
20857; telephone (301) 443-1127.

    Dated: April 10, 2012.
Reva Harris,
Acting Director, Division of Policy and Information Coordination.
[FR Doc. 2012-9135 Filed 4-16-12; 8:45 am]
BILLING CODE 4165-15-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.